Antibody Therapeutics for Life

Notices


No Title Written by Written date Inquire
89   PharmAbcine' PMC-403 is featured on Pharma Tech Outlook   PharmAbcine   2020-12-22   352  
88   PharmAbcine discloses an E-poster of updated interim result of the ongoing olinvacimab and pembrolizumab combo trial at SABCS 2020   PharmAbcine   2020-12-16   471  
87   PharmAbcine is invited to give a presentation at the K-NIBRT Kick Off Conference 2020   PharmAbcine   2020-12-08   551  
86   PharmAbcine at SNO 2020   PharmAbcine   2020-11-25   501  
85   PharmAbcine is invited to give a presentation at the 41st AKBC-KABC 2020.   PharmAbcine   2020-11-17   596  
84   PharmAbcine,is invited to give a presentation at IUMS2020.   PharmAbcine   2020-11-16   399  
83   PharmAbcine to participate at BIO-Europe 2020   PharmAbcine   2020-10-27   655  
82   PharmAbcine Present Preclinical Data of Blood Vessel Stabilizing PMC-403 at 2020 AACR E-poster   PharmAbcine   2020-06-22   5,912  
81   PharmAbcine, AACR Annual Meeting 2020 Online Planner   PharmAbcine   2020-06-17   7,068  
80   PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I   PharmAbcine   2020-06-12   5,609